Intensive Diabetes Management, 7th Ed.
Current 7th edition with ADA’s newest standards of care! This book covers the newest evidence-based research in intensive diabetes patient care for Type 1 and Type 2 diabetes), which has been proven effective in controlling or delaying diabetes consequences, and is now the rule, instead of the exception in care. The data, guidelines, therapies, and procedures reflect the latest positions of the American Diabetes Association’s standards of care.
Level 2 & 3 CPE
Suggested Performance Indicators: 1.1.4, 1.2.1, 2.1.3, 4.1.2, 4.2.7, 6.1.2, 6.1.8, 6.2.3, 6.3.8, 8.1.1, 8.1.2, 8.1.3, 8.1.5, 8.3.1, 8.3.5, 8.3.7, 10.2.9
CPE Type: 740 Online/Web-based
Upon successful completion, the users will be able to:
1. Discuss three benefits of intensive diabetes management not achieved through less intensive insulin regulation and diabetes care.
2. Define and explain significance of each to diabetes: glutamine, ketoneogenesis, glucagon, and insulin.
3. Explain what a defective catecholamine response means to a person with diabetes.
4. Describe the patient’s responsibility in the multidiscipline team approach to diabetes care.
5. Describe carbohydrate counting and how insulin is altered to account for carbohydrate calories, added exercise, or illness.
6. List two ways diabetes professionals can address a patient’s burnout and fear of hypoglycemia.
7. Describe three situations where family therapy is recommended.
8. Identify the recommended premeal blood glucose levels in the following: adult male, pregnant female, and an adolescent.
9. Compare the actions of the following insulin types: regular, glarine, detemir, and NPH.
10. Explain three reasons why the abdomen is a preferred insulin injection site.
11. Describe the most flexible insulin regime for meal size and timing.
12. Discuss how the insulin pump maintains more normal blood sugar levels and give two precautions on its use.
13. Identify the average basal insulin pump rate for patients with T1D.
14. Identify how much carbohydrate one unit of insulin normally covers.
15. Discuss two reasons why A1C is significant for people with diabetes.
16. Describe two possible benefits an overweight or obese person with diabetes might receive from losing weight.
Why we chose this book
The American Diabetes Association is known for its timely, high-quality books written by experts. Health professionals have like our selections of ADA’s books, so we continue to produce new courses as new editions are released.
About the author
Devin Steenkamp, MD, is the Director of the Clinical Diabetes Program at Boston Medical Center and an Assistant Professor of Medicine at Boston University School of Medicine in Endocrinology, Diabetes, and Nutrition. His clinical practice and research are focused on the application of diabetes technologies in patient care.